Okeiro website preview
growth medtech Karlsruhe 3 sources
Own this company? Claim the page to unlock editing and verified-owner badge.

Okeiro provides a medical platform for transplant and chronic disease management, utilizing validated predictive algorithms for patient monitoring, care, and clinical research.

Classification

Karlsruhe DE growth medtech saas b2b ai HealthWellnessPersonalizedInsightsTechnology

Profile

Tech stack
AI-powered platform, iBox algorithm

Funding

Funding details not yet available.

Business model
💡 Value Proposition

A medical platform using validated predictive algorithms to transform monitoring for transplant and chronic disease patients, enabling proactive care.

👥 Customer Segments

Healthcare providers and clinical research organizations managing transplant and chronic disease patient populations.

💰 Revenue Model

SaaS subscriptions for healthcare institutions and research organizations

📡 Channels

Direct sales to healthcare providers through dedicated website and outreach

🤝 Key Partnerships

state lottery operators (e.g., Lotto & Slipstream, DEG), payment providers (PayPal)

⚖️ Cost Structure

R&D for algorithm development, platform hosting, and healthcare compliance certification

🏗️ Key Resources

Validated predictive algorithms for clinical care and research, and a specialized platform for transplant and chronic disease monitoring.

⚙️ Key Activities

Developing and validating predictive algorithms, maintaining the medical platform, and supporting clinical care and research workflows.

💬 Customer Relationships

Sales-led relationships with healthcare institutions requiring clinical validation

Strategic analysis
🏁 Competitive landscape

Competes in digital health for chronic care; differentiates via validated predictive algorithms specifically for transplant and chronic disease monitoring.

🎯 Market pains

Inefficient patient monitoring for transplants and chronic conditions; need for validated predictive tools to support clinical care and research.

💎 Improvement suggestions
  • Amplify Thought-Leadership & Social Presence
♟️ Strategic implications
  • Map Current Customer Journey - Identify friction points in onboarding and alert triage; prioritize UI enhancements that reduce clinician
🛡️ Credibility notes
  • Funding Validation - €10 M Series A (2025) led by Alven and Red River West demonstrates investor confidence and provides runway for scali
Team

Team details not yet available.

Investors

No investors recorded yet.

Sources & references

Web verified · 3 sources
Enriched 18 Jun 2026